The Native Antigen Company (NAC) has released a highly purified Bordetella pertussis toxin.
This product has been developed in response to the increasing pressure on the IVD industry to supply highly specific, cost-effective antibody capture systems, which are needed for monitoring vaccination programmes.
FHA, a major cause of false results, is absent from the preparation.
Manufacturing procedures are geared to ensure minimal lot-to-lot variation.
The toxin is offered in lyophilised format for ease of storage and use.
According to the company, pertussis (whooping cough), caused by Bordetella pertussis, is a major cause of childhood morbidity and mortality.
